Palo Alto, CA, United States of America

Ken-ichi Arai


Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 198(Granted Patents)


Company Filing History:


Years Active: 1987-1999

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Ken-ichi Arai: Innovator in Molecular Biology

Introduction

Ken-ichi Arai is a prominent inventor based in Palo Alto, California, known for his significant contributions to molecular biology. He holds a total of 10 patents, showcasing his innovative work in the field.

Latest Patents

Among his latest patents, Arai has developed nucleic acids encoding human interleukin-4. These mammalian proteins and their muteins, designated interleukin-4s (IL-4s), exhibit both B cell growth factor activity and T cell growth factor activity. The compounds include native human and murine IL-4s, muteins thereof, and nucleic acids that are effectively homologous to disclosed cDNAs, which are capable of coding for mammalian IL-4s and their muteins. Additionally, he has patented a method for treating rheumatoid arthritis by administering human Interleukin-4 (IL-4) to individuals afflicted with the disease. This method involves the use of a pharmaceutically acceptable carrier with a dosage ranging from 1 µg to 100 mg.

Career Highlights

Throughout his career, Ken-ichi Arai has worked with notable organizations such as Schering Corporation and Dnax Research Institute of Molecular and Cellular Biology, Inc. His work has significantly advanced the understanding and treatment of various medical conditions.

Collaborations

Arai has collaborated with esteemed colleagues, including Frank D. Lee and Takashi Yokota, contributing to the advancement of research in molecular biology.

Conclusion

Ken-ichi Arai's innovative work in the field of molecular biology, particularly in the development of interleukin-4 and its applications, highlights his importance as an inventor. His contributions continue to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…